Sigma-Aldrich
Life Science

Antibodies
Automation
Cancer Research
Cell Culture
Cell Signaling and Neuroscience
Product Lines
Product Highlights
New Literature
Ion Channels
Key Resources
Cell Signaling Web Tools
New Products
PathFinder
Pathway Slides & Charts
Pharm. Action Table
Poster Gallery
Protocols
Search Tools
eHandbook
Custom Synthesis
Drug Discovery
Epigenetics
Functional Genomics and RNAi
Metabolomics
Molecular Biology
Neuroscience
Nutrition Research
Obesity Research
Peptides and Proteins
Plant Biotechnology
Proteomics and Protein Expr.
Stable Isotopes
Stem Cell Biology
Your Favorite Gene - Search
Life Science Innovations
PathFinder

 

Akt Signaling

Top Border
Left Border  Right Border
Left Corner Back Download Forward Sigma-Aldrich Right Corner

Akt Signaling

The serine/threonine protein kinase Akt/PKB is the cellular homologue of the viral oncogene v-Akt and is activated by various growth and survival factors. In mammals, there are three known isoforms of the Akt kinase, Akt1, Akt2, and Akt3. Many cell surface receptors induce the production of second messengers that activate phosphoinositide 3-kinase (PI3K). Akt is located downstream of PI3K and, therefore, functions as part of a wortmannin-sensitive signaling, pathway. PI3K generates phosphorylated phosphatidylinositides (PI-3,4-P2 and PI-3,4,5-P3) in the cell membrane that bind to the amino-terminal pleckstrin homology (PH) domain of Akt. PI-3,4-P2 and PI-3,4,5-P3 also activate phosphoinositide-dependent kinase (PDK) which phosphorylates Thr308 of membrane-bound Akt. Ser473 is phosphorylated by integrin-linked kinase (ILK). Activated Akt promotes cell survival through two distinct pathways: 1) Akt inhibits apoptosis by phosphorylating the Bad component of the Bad/Bcl-XL complex. Phosphorylated Bad binds to 14-3-3 causing dissociation of the Bad/Bcl-XL complex and allowing cell survival. 2) Akt activates IKK-a that ultimately leads to NF-kb activation and cell survival.

Back to Top

References:

Yoganathan, T.N., et al., Integrin-linked kinase (ILK) : a "hot" therapeutic target. Biochem. Pharmacol., 60 1115-1119 (2000).

Galetic, I., et al., Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase-significance for diabetes and cancer. Pharmacol. Ther., 82, 409-425 (1999).

Kandel, E.S., and Hay, N., The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res., 253, 210-229 (1999).